Treatment of Pregabalin Toxicity by Hemodialysis in a Patient With Kidney Failure

American Journal of Kidney Diseases

Volumn 54, Issue 6, 2009, Pages 1127-1130

  Yoo, Lawrence ^a   Matalon, Daniel ^a,b   Hoffman, Robert S ^a,b   Goldfarb, David S ^a,b,c  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

aminobutyric acid; 3 Isobutyl aminobutyric acid (GABA); gabapentin; intoxication; Lyrica; poisoning; renal dialysis

Indexed keywords

BICARBONATE; CEFEPIME; CHLORIDE; CREATININE; ETIRACETAM; FENTANYL; LINEZOLID; MIDODRINE; PANTOPRAZOLE; PLASMA PROTEIN; POTASSIUM; PREGABALIN; SEVELAMER; SODIUM; VANCOMYCIN;

ADULT; ARTICLE; ARTIFICIAL KIDNEY; BLADDER CANCER; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CASE REPORT; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG OVERDOSE; FEMALE; FEVER; HEART RATE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HYPOTENSION; KIDNEY FAILURE; LABORATORY TEST; MEDICATION ERROR; MOLECULAR WEIGHT; MYOCLONUS; NEUROPATHIC PAIN; OBSTRUCTIVE UROPATHY; PELVIC INFLAMMATORY DISEASE; PHYSICAL EXAMINATION; REMISSION; RENAL REPLACEMENT THERAPY; SEIZURE; SYMPTOM; UREA NITROGEN BLOOD LEVEL;

ADULT; ANALGESICS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; KIDNEY FAILURE, CHRONIC; NEURALGIA; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 70449674849     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.04.014     Document Type: Article

References (18)

1. Asconape J., Diedrich A., and DellaBadia J. Myoclonus associated with the use of gabapentin. Epilepsia 41 (2000) 479-481
2. Zhang C., Glenn D.G., Bell W.L., and O'Donovan C.A. Gabapentin-induced myoclonus in end-stage renal disease. Epilepsia 46 (2005) 156-158
3. Zareba G. Pregabalin: A new agent for the treatment of neuropathic pain. Drugs Today (Barc) 41 (2005) 509-516
4. Olaizola I., Ellger T., Young P., Bosebeck F., Evers S., and Kellinghaus C. Pregabalin-associated acute psychosis and epileptiform EEG-changes. Seizure 15 (2006) 208-210
5. Braga A.J., and Chidley K. Self-poisoning with lamotrigine and pregabalin. Anaesthesia 62 (2007) 524-527
6. Huppertz H.J., Feuerstein T.J., and Schulze-Bonhage A. Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin. Epilepsia 42 (2001) 790-792
7. Miller R., Frame B., Corrigan B., et al. Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures. Clin Pharmacol Ther 73 (2003) 491-505
8. Brodie M.J., Wilson E.A., Wesche D.L., et al. Pregabalin drug interaction studies: Lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy. Epilepsia 46 (2005) 1407-1413
9. Selak I. Pregabalin (Pfizer). Curr Opin Investig Drugs 2 (2001) 828-834
10. Bialer M., Johannessen S.I., Kupferberg H.J., Levy R.H., Loiseau P., and Perucca E. Progress report on new antiepileptic drugs: A summary of the Fourth Eilat Conference (EILAT IV). Epilepsy Res 34 (1999) 1-41
11. Bialer M., Johannessen S.I., Kupferberg H.J., Levy R.H., Loiseau P., and Perucca E. Progress report on new antiepileptic drugs: A summary of the Sixth Eilat Conference (EILAT VI). Epilepsy Res 51 (2002) 31-71
12. Randinitis E.J., Posvar E.L., Alvey C.W., Sedman A.J., Cook J.A., and Bockbrader H.N. Pharmacokinetics of pregabalin in subjects with various degrees of renal function. J Clin Pharmacol 43 (2003) 277-283
13. Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 45 suppl 6 (2004) S13-S18
14. Bialer M., Johannessen S.I., Kupferberg H.J., Levy R.H., Perucca E., and Tomson T. Progress report on new antiepileptic drugs: A summary of the Eighth Eilat Conference (EILAT VIII). Epilepsy Res 73 (2007) 1-52
15. Arroyo S., Anhut H., Kugler A.R., et al. Pregabalin add-on treatment: A randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 45 (2004) 20-27
16. Crofford L.J., Rowbotham M.C., Mease P.J., et al. Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 52 (2005) 1264-1273
17. Lesser H., Sharma U., LaMoreaux L., and Poole R.M. Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized controlled trial. Neurology 63 (2004) 2104-2110
18. Naranjo C.A., Busto U., and Sellers E.M. Difficulties in assessing adverse drug reactions in clinical trials. Prog Neuropsychopharmacol Biol Psychiatry 6 (1982) 651-657